Browse by Person

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.


Pollock, R.F., Heller, S., Pieber, T.R. et al. (6 more authors) (2019) Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9). Diabetes, Obesity and Metabolism, 21 (7). pp. 1706-1714. ISSN 1462-8902

DeVries, J.H., Bailey, T.S., Bhargava, A. et al. (9 more authors) (2018) Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: a post hoc analysis of the SWITCH trials. Diabetes, Obesity and Metabolism. ISSN 1462-8902

Pieber, T.R., Marso, S.P., McGuire, D.K. et al. (14 more authors) (2017) DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. ISSN 0012-186X

Heller, S., Mathieu, C., Kapur, R. et al. (2 more authors) (2016) A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia. Diabetic Medicine, 33 (4). pp. 478-487. ISSN 0742-3071

This list was generated on Sat May 1 18:44:23 2021 BST.